How Can Bispecific Antibody Therapy Care Partners Be Proactive?
https://vimeo.com/940909348 What are some ways for myeloma bispecific antibody therapy care partners to be proactive? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute shares lifestyle modifications, reasons to speak up…
Bispecific Antibody Therapy Support | Care Team Members and Resources
https://vimeo.com/940909300 What should myeloma patients know about bispecific antibody therapy support? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses care team members and support resources for bispecific antibody therapy…
What Is the Role of a Care Partner in Bispecific Antibody Therapy?
https://vimeo.com/940909265 How can a myeloma care partner support a bispecific antibody therapy patient? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains ways that care partners can offer logistical and…
Bispecific Antibody Therapy | What Is the Treatment Duration and Response?
https://vimeo.com/940909235 What can myeloma bispecific antibody therapy patients expect for treatment duration and response? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses treatment factors that may impact response, common…
Bispecific Antibody Therapy | Managing Side Effects
https://vimeo.com/940909187?fl=pl&fe=sh What should myeloma bispecific antibody therapy patients know about managing side effects? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses common short-term and long-term side effects, members of…
How Is Bispecific Antibody Therapy Administered?
https://vimeo.com/940909156 How is myeloma bispecific antibody therapy given to patients? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains how the treatment is administered in the body, hospital types to…
Bispecific Antibodies for Myeloma | Patient Eligibility Requirements
https://vimeo.com/940909113 What are the myeloma patient eligibility requirements for bispecific antibodies? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses patient types that work well with bispecific antibody therapy, patient…
How Has Bispecific Antibody Therapy Impacted Myeloma Care?
Advancements in Lung Cancer Clinical Trials | Updates for Veterans
How can veterans help move lung cancer clinical trial advancements forward? Expert Dr. Drew Moghanaki from UCLA Health explains clinical trial groups that need more participants, available support resources for…
Lung Cancer Care for Veterans: Advancements in Radiation Oncology
https://vimeo.com/938464223 What should veterans with lung cancer know about radiation oncology advancements? Expert Dr. Drew Moghanaki from UCLA Health explains recent advancements in radiation oncology and radiotherapy, where the advanced…
Are There Lung Cancer Outcome Disparities for Veterans?
https://vimeo.com/938464312 Do lung cancer outcome disparities exist for veterans? Expert Dr. Drew Moghanaki from UCLA Health discusses veteran outcome studies for civilian versus VA healthcare, efforts on improving outcomes over…
Veteran Lung Cancer Risk | Understanding Exposures and Screening Protocols
http://vimeo.com/video/938464405 What’s important for veterans to know about lung cancer risk? Expert Dr. Drew Moghanaki from UCLA Health discusses known veteran lung cancer risk factors, screening recommendations, and proactive patient…